Hexagon Capital Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,876
| Closed | -$492K | – | 298 |
|
|
2025
Q1 | $492K | Buy |
4,876
+114
| +2% | +$11.5K | 0.09% | 106 |
|
|
2024
Q4 | $425K | Buy |
4,762
+127
| +3% | +$11.3K | 0.08% | 119 |
|
|
2024
Q3 | $388K | Sell |
4,635
-49
| -1% | -$4.11K | 0.08% | 121 |
|
|
2024
Q2 | $361K | Sell |
4,684
-195
| -4% | -$15K | 0.08% | 131 |
|
|
2024
Q1 | $334K | Sell |
4,879
-140
| -3% | -$9.59K | 0.07% | 133 |
|
|
2023
Q4 | $290K | Buy |
5,019
+136
| +3% | +$7.86K | 0.07% | 146 |
|
|
2023
Q3 | $258K | Sell |
4,883
-30
| -0.6% | -$1.58K | 0.07% | 137 |
|
|
2023
Q2 | $266K | Sell |
4,913
-199
| -4% | -$10.8K | 0.07% | 133 |
|
|
2023
Q1 | $256K | Sell |
5,112
-450
| -8% | -$22.5K | 0.07% | 126 |
|
|
2022
Q4 | $257K | Sell |
5,562
-252
| -4% | -$11.7K | 0.07% | 127 |
|
|
2022
Q3 | $225K | Sell |
5,814
-1,130
| -16% | -$43.7K | 0.07% | 137 |
|
|
2022
Q2 | $259K | Sell |
6,944
-231
| -3% | -$8.62K | 0.08% | 143 |
|
|
2022
Q1 | $318K | Hold |
7,175
| – | – | 0.08% | 140 |
|
|
2021
Q4 | $305K | Sell |
7,175
-150
| -2% | -$6.38K | 0.08% | 136 |
|
|
2021
Q3 | $318K | Sell |
7,325
-643
| -8% | -$27.9K | 0.09% | 115 |
|
|
2021
Q2 | $341K | Sell |
7,968
-6,739
| -46% | -$288K | 0.09% | 108 |
|
|
2021
Q1 | $568K | Sell |
14,707
-3,659
| -20% | -$141K | 0.16% | 62 |
|
|
2020
Q4 | $660K | Buy |
18,366
+950
| +5% | +$34.1K | 0.19% | 48 |
|
|
2020
Q3 | $601K | Buy |
+17,416
| New | +$601K | 0.19% | 49 |
|